Credera, a global consulting firm focused on transformation, MarTech, artificial intelligence (AI), and technology,today announced the achievement of the Amazon Web Services (AWS) Energy and Utilities Competency.This designation recognizes Credera as an AWS Premier Tier Services Partner with deep expertise in helping energy and utilities companies leverage AWS technologies to enhance their operations, drive digital […]
Patients can choose a more personalized approach to managing their cardiology care Concierge Choice Physicians (CCP), the nation's leading full- service concierge medical service provider, today announced that Evan Caruso, MD, FACC, a cardiologist with Heart Specialists of Sarasota in Sarasota, FL, has enrolled in the company's Hybrid Choice™ program – an enhanced service that
INVINCIBLE-3 Study continues to recruit patients with leiomyosarcoma, liposarcoma and undifferentiated pleomorphic sarcoma; authorizations for the INVINCIBLE-3 Study have been received in the U.S., Canada, Europe and Australia Intensity Therapeutics, Inc. (Nasdaq: INTS), (“Intensity” or “the Company”) a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies
DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) — Qsic, the global intelligent in-store audio platform that elevates the in-store experience and drives incremental revenue, today announced that it closed a $25 million Series B funding round led by Hedosophia. Powering in-store audio and retail media for leading retailers and QSRs like 7-Eleven, Coles Express and McDonald's
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on real estate private credit, today announced that it has originated a $58 million acquisition loan to The Related Group and 13th Floor Investments for the purchase of Arium Lincoln Pointe, a 285-unit multifamily waterfront
Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) — March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to MB-105, the company's
(NASDAQ:SXTP),(NASDAQ:SXTPW), Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a presumptive diagnosis of chronic babesiosis in outpatient settings. Enrollment expected to commence Q3 2025. WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company
A single app for consumers' whole health that provides convenience, savings and ease CVS Health® (NYSE: CVS) today announced the launch of the CVS Health app. New features of the app will bring together all CVS Health has to offer to consumers, helping make health care more accessible, affordable and convenient. https://mma.prnewswire.com/media/487051/CVS_Health_Logo.jpg “As a company,
Glance's AI + Human Maturity Model™ gives CX leaders clarity in balanced CX for 2025 and beyond Glance, a leading provider of Guided Customer Experience (CX) solutions, published its AI + Human Maturity Model™ for Customer Experience, a resource for CX and product leaders seeking to harmonize artificial intelligence and human expertise in their customer
EIT Digital is proud to announce the launch of the (d)Academy, a cutting-edge digital skills platform developed to address the critical shortage of digital talent across Europe. Created in partnership with Abodoo, a leader in remote talent-matching, the (d)Academy is designed to tackle a challenge that affects individuals, businesses, and entire economies: over 75% of